Tag Archives: Yaron Werber

Analysts’ Top Healthcare Picks: Argenx Se (ARGX), Immunomedics (IMMU)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Argenx Se (ARGX – Research Report), Immunomedics (IMMU – Research Report) and GlycoMimetics (GLYC – Research Report) with bullish sentiments. Argenx Se

Stoke Therapeutics (STOK) Receives a Buy from Cowen & Co.

In a report released today, Yaron Werber from Cowen & Co. maintained a Buy rating on Stoke Therapeutics (STOK – Research Report). The company’s shares closed last Monday at $18.69, close to its 52-week low of $15.82. According to TipRanks.com,

Cowen & Co. Maintains a Buy Rating on BeiGene (BGNE)

In a report released today, Yaron Werber from Cowen & Co. maintained a Buy rating on BeiGene (BGNE – Research Report), with a price target of $200.00. The company’s shares closed last Monday at $164.06. According to TipRanks.com, Werber is

Analysts Offer Insights on Healthcare Companies: Exelixis (NASDAQ: EXEL), NeuBase Therapeutics (NASDAQ: NBSE) and Theravance Biopharma (NASDAQ: TBPH)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Exelixis (EXEL – Research Report), NeuBase Therapeutics (NBSE – Research Report) and Theravance Biopharma (TBPH – Research Report) with bullish sentiments. Exelixis

Ultragenyx Pharmaceutical (RARE) Receives a Rating Update from a Top Analyst

Cowen & Co. analyst Yaron Werber maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target of $75.00. The company’s shares closed last Monday at $62.90. According to TipRanks.com, Werber is a top

Analysts Offer Insights on Healthcare Companies: Amgen (NASDAQ: AMGN) and Miragen Therapeutics (NASDAQ: MGEN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Amgen (AMGN – Research Report) and Miragen Therapeutics (MGEN – Research Report) with bullish sentiments. Amgen (AMGN) In a report released today,